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Synchrotron-generated microbeam radiotherapy holds great promise for future
treatment, but the high dose gradients present conventional dosimetry with a
challenge. Measuring the important peak-to-valley dose ratio (PVDR) of a
microbeam-collimated synchrotron source requires both a dosimeter and an
analysis method capable of exceptional spatial resolution. The PVDR is of great
interest since it is the limiting factor for potential application of the microbeam
radiation therapy technique clinically for its tissue-sparing properties (i.e. the
valley dose should be below the tolerance of normal tissue). In this work a new
method of measuring the dose response of PRESAGE dosimeters is introduced
using the fluorescence from a 638 nm laser on a confocal laser-scanning
microscope. This fluorescent microscopy method produces dosimetry data at a
pixel size as low as 78 nm, giving a much better spatial resolution than optical
computed tomography, which is normally used for scanning PRESAGE
dosimeters. Using this technique the PVDR of the BL28B2 microbeam at the
SPring-8 synchrotron in Japan is estimated to be approximately 52:1 at a depth
of 2.5 mm. The PVDR was also estimated with EBT2 GAFchromic films as
30.5:1 at the surface in order to compare the PRESAGE fluorescent results with
a more established dosimetry system. This estimation is in good agreement with
previously measured ratios using other dosimeters and Monte Carlo simulations.
This means that it is possible to use PRESAGE dosimeters with confocal
microscopy for the determination of PVDR.
Keywords: PRESAGE fluorescent dosimetry.
1. Introduction
Microbeam X-ray irradiation offers an innovative and
promising modality for delivering high dose to well defined
sections of tumour-bearing tissue whilst sparing the adjacent
healthy tissue. This approach relies on the superior regen-
erative ability of healthy cells compared with tumourous cells
when repopulating a depleted region (Dilmanian et al., 2007).
Microbeam radiation therapy (MRT) requires a minimally
divergent radiation source that passes through a collimator.
For this purpose a synchrotron is used to generate highly
collimated radiation. Such beams have been shown to have
potential for the treatment of brain tumours that have high
radiation resistance (Dilmanian et al., 2007). MRTwill soon be
used in clinical trials at the ESRF facility, and offers significant
hope for treating tumours that could not be treated with
conventional radiotherapy (Martinez-Rovira et al., 2010). In
order to assess the potential clinical usefulness of a MRT
beamline, the peak-to-valley dose ratio (PVDR) of the
beamline must be thoroughly investigated, in order to ensure
that a lethal dose is being delivered to the peak region but
a sub-lethal dose is being delivered to the valley region.
Numerous Monte Carlo studies have been performed to
compute the dose profile of these beams (De Felici et al., 2005;
Nettelbeck et al., 2009; Siegbahn et al., 2006; Spiga et al., 2007),
but experimental verification of the dosimetry is highly chal-
lenging. To this end, the microbeam’s high dose gradient
demands a dosimetry system that can faithfully resolve to
micrometre-level precision. Also, a three-dimensional dosi-
meter should be used in order to validate the lack of beam
diffusion.
There are now several options to choose from which to
fulfil the requirement for high-resolution three-dimensional
dosimetry, including Fricke gels and polyacrylamide gels.
These dosimeters are limited by their requirement of a
container, which makes them unable to resolve surface dose
since the container will be unreactive. In contrast, PRESAGE
dosimeters are solid plastic based and therefore do not
require any container, thus making them an attractive option
for creating a fully defined three-dimensional model of
absorbed dose, including surface dose. PRESAGE is normally
scanned using optical computed tomography (OCT) equip-
ment such as the OCTOPUS system (Guo et al., 2006;
Sakhalkar et al., 2009). This system uses computed tomo-
graphy reconstruction of transmitted light images to produce
a three-dimensional opacity distribution, which is a function
of absorbed dose. The OCTOPUS system uses a laser of
wavelength 633 nm, as this wavelength has been experimen-
tally determined as having the peak visible absorbance for
the oxidized version of leucomalachite green, the radiation-
sensitive ingredient in PRESAGE (Adamovics & Maryanski,
2006). Recent work by Rahman et al. (2010) makes use of
microscopic techniques in order to improve the spatial reso-
lution of the OCT system, down to a spatial resolution of
25 mm.
Some of the advantages of PRESAGE dosimeters over
other three-dimensional gel dosimeters are its low ion diffu-
sion, approximate tissue equivalence, longer shelf life and the
uniform response to differing energies and dose rates. Because
of the solid polyurethane matrix, it has also shown to with-
stand periods of heat (Adamovics & Maryanski, 2006). The
low ion diffusion of the polyurethane base makes PRESAGE
an attractive option for measuring high dose gradients, such as
collimated synchrotron microbeams, which requires dosimetry
to be accurate to smaller than a cell in order to capture the
biological effects of MRT. These advantages of the PRESAGE
system have recently been utilized for the commissioning of
a radiosurgery field less than 1 cm wide (Clift et al., 2010).
PRESAGE dosimetry has also recently been used to measure
the dose delivered by the beam produced at the European
Synchrotron Radiation Facility using computed tomography
reconstruction of microscopic transmission data to achieve a
resolution of 2.7 mm (Doran et al., 2010). This work illustrated
the capabilities of PRESAGE to accurately record a very high
resolution dose image, but the technique used still required
a light source to traverse the entire width of the rod, which
introduces alignment uncertainty when measuring a MRT-
collimated sample.
Although optically stimulated luminescence is an estab-
lished form of dosimetry using Al2O3-based compounds
(Yukihara et al., 2008), PRESAGE has not yet been used in
this manner. In this study the PVDR of the microbeams
produced with the BL28B2 spectrum and set-up will be eval-
uated with PRESAGE and GAFchromic films. The
GAFchromic film measurements taken in this work allow for
comparison with previous work conducted on the same
beamline by Crosbie et al. (2008), who used such films for the
estimation of PVDR. This collimator produces microbeams
with a nominal width of 25 mm separated by a gap of 175 mm
(200 mm centre-to-centre). The PRESAGE gel was then
analysed using the fluorescent channels of a confocal micro-
scope, and compared with the results obtained on
GAFchromic films.
2. Materials and methods
2.1. PRESAGE dosimeters
The PRESAGE rods used (20 mm diameter  125 mm
long) were purchased from Heuris Pharma, Skillman, NJ,
USA, made using the method outlined by Adamovics &
Maryanski (2006).
2.2. Radiochromic films
The peak-to-valley ratio was determined using GAF-
chromic EBT2, purchased from International Specialty
Products (ISP Technologies). EBT films were selected to
provide a comparison with an established PVDR measure-
ment technique as used by Crosbie et al. (2008).
2.3. Irradiation
Samples of PRESAGE rods and EBT2 films were irradiated
at the SPring-8 synchrotron facility in Harima, Japan, on
beamline BL28B2 in November 2009. A collimator made from
5 mm  20 mm plates of tungsten (175 mm thick) and kapton
(25 mm thick) was used; it produced 25 mm-high beams with a
gap of 175 mm, with the total beam pattern size being 1 mm
high  20 mm wide. Fig. 1 shows the set-up for irradiation. A
3 mm Cu filter was used, giving a peak fluence energy of
90 keV. The peak dose rate (air kerma) in the peak region was
assumed as 120 Gy s1, and the half-value layer was assumed
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Figure 1
Top: schematic of the irradiation set-up at BL28B2. Bottom: photograph
illustrating the set-up.
to be 2.2 mm Cu, as previously calculated (Nariyama et al.,
2009). The spectrum of energy used in this work is specified in
Fig. 1 of Nariyama et al. (2009), as calculated by SPECTRA
codes. Dose was calculated as a function of exposure time
using the shutter system, where the width of a shutter gap is set
and the shutter is then moved across the beam at a well
controlled speed, to produce a known exposure time. The
collimator was located 40 m downstream from the source;
beam divergence is thought to be negligible. The collimator
set-up allowed for the irradiation of four microbeams at a
time, for a total height of 1 mm, after which the target stand
was moved to allow further microbeams. A total of eight peaks
and seven valleys were made at each dose point for both films
and PRESAGE rods. The peak dose rate (air kerma) was
assumed to be 120 Gy s1 (Nariyama et al., 2009), and the dose
was calculated as a function of exposure time using the shutter
system.
Fig. 2 illustrates a PRESAGE rod, highlighting the section
that was irradiated at SPring-8. The insert of this figure shows
the fluorescent scan of that section from the confocal laser
scanning microscope (CLSM). For the analysis of beam
diffusion at different depths of the PRESAGE, another rod
was irradiated lengthwise instead of from the side. After
irradiation, all rods were stored in a refrigerator (277 K)
protected from UV light for approximately one month before
being read with fluorescent microscopy.
2.4. Fluorescent microscopy for irradiated PRESAGE
dosimetry
A Nikon Eclipse Ti-E A1 CLSM was used to scan the
PRESAGE dosimeters (Nikon Instruments, USA), using 10
and 40 objectives. Images were captured using the NIS-
Element imaging software (version 3.2). The microscope is
equipped with four lasers of wavelengths 405 nm, 488 nm,
561 nm, 638 nm. It also has four detectors with sensitivity
spectra of 662–737 nm, 570–620 nm, 500–550 nm and 425–
475 nm. The best fluorescence from the irradiated PRESAGE
rods, compared with non-irradiated control rods, was achieved
using the 638 nm laser and the 662–737 nm detector. This is
the combination of laser and detector used for this study.
For consistency, settings such as pinhole, laser power and
filters were fixed. The focal depth was also fixed at 2.5 mm,
since shallower depths led to distortions owing to the curved
surface of the rods. The gain on the photomultiplier tube
(PMT) is probably the most important parameter for the
fluorescent response, as it determines the fluorescence at
which the PMT saturates, and therefore the useful range of the
PMT. The PMT gain was selected and fixed at a value which
gave a curve for 0–15 Gy fluorescent response that did not rise
above 50% of the saturation level of the PMT. According to
manufacturer’s specifications, the laser diode power stability is
ensured to be constant to within 2%. All images taken were an
average of eight scans to reduce image noise, and all seven
valleys were sampled for the determination of PVDRs.
The images were saved as jp2000 files and examined using
the NIS-Element AR software (version 3.10). The peak and
valley regions were sampled, with the mean fluorescence value
of 16 pixels (20 mm sample width) giving a reading of fluor-
escence, as a 12-bit number (0–4095). With the exception of
experiment 5 (described in x3.5), all data were collected using
a 10 objective lens and recorded as 512  512 images, giving
a pixel size of 1.25 mm.
2.5. Flatbed scanning for GAF films
The GAFchromic film was analysed using an Epson V700
Professional scanner running Epson Scan (version 2.80E), at a
resolution of 9600 dots per inch. The resulting image was
saved as a TIF file. The three colour channels were split, and
only the red channel data were analysed owing to its cleaner
response than the blue or green channels, as recommended in
EBT2 film specifications and other published data (Nariyama
et al., 2009; Hartmann et al., 2010). The images taken were
saved as compressionless TIF files and examined using ImageJ
(version 1.37). The peak and valley regions were sampled as
shown in Fig. 3 with a sampling width of 20 mm from the red
channel response value giving a reading of optical density
(OD), as an 8-bit number (0–255), for both peaks and valleys.
All seven valleys were sampled for the determination of
PVDRs. Data were then exported to Minitab (version 15) for
analysis.
2.6. Calibration curve fitting by regression analysis
Calibration response curves were developed by scanning
microbeam-irradiated PRESAGE rods with peak doses
between 0 and 15 Gy, and EBT2 films with peak doses
between 2.5 and 75 Gy. A polynomial was fitted to the
PRESAGE response, and a logarithmic response was fitted to
the EBT2 response by regression analysis using Microsoft
Excel 2003. This was done to coincide with the range of valley
doses that would be measured. Subsequently, the valley
regions of higher-dose irradiations were compared with these
curves, and doses were interpolated for the valley regions of
the microbeam when a known dose was delivered to the peak
region. From this interpolated data the peak-to-valley ratio
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Figure 2
One of the rods of the PRESAGE used for this study, irradiated with
different intensities of microbeams. The arrow points to an array of 16
microbeams (each 25 mm wide), difficult to distinguish with the human
eye. Insert: fluorescence of a 638 nm laser on the PRESAGE dosimeter,
under 10 objective magnification.
was calculated for individual valleys, and compared between
the different dosimeters. This polynomial curve-fitting proce-
dure is derived from Crosbie et al. (2008).
2.7. Statistical analysis
All student’s t-tests mentioned in this paper were
performed using Minitab (version 15), with a threshold of p =
0.05 used for establishing significance. Equal variances were
not assumed.
3. Experimental outline
The following experiments will be described in this paper,
using the methods and materials outlined in x2.
3.1. Experiment 1: evaluating the PVDR using EBT2 film
dosimetry
GAFchromic EBT2 film is irradiated by an array of
microbeams to various known peak doses. The measured OD
was used to create a calibration curve against the delivered
dose. Further EBT2 film is irradiation to peak doses that are
far above the expected saturation dose that the film is capable
of measuring to bring the valley dose up to the sensitive range.
This value is compared against the calibration curve to
determine the delivered valley dose and thus the PVDR. The
PVDR is estimated using the formula
PVDR ¼ x=DvalleyðxÞ; ð1Þ
where x is the dose to the peak (in Gy), and Dvalley(x) is the
corresponding dose delivered to the valley when the peak
dose is x. The dose is evaluated as a function of the OD of light
through the GAFchromic film; this function will be empirically
determined. The EBT2 film peak OD responses from 2.5 Gy
to 75 Gy was measured to establish the OD calibration curve,
and the valleys from peak doses of 300 Gy to 800 Gy were
then measured to estimate the PVDR. Although the calibra-
tion range of 2.5–75 Gy exceeds the specified dose range of the
films of 40 Gy (Nariyama et al., 2009), an accurate logarithmic
approximation was still produced over this range.
3.2. Experiment 2: evaluating the PVDR using PRESAGE
dosimetry
Using the same mathematical approach outlined above for
experiment 1, PRESAGE rods were irradiated by an array of
microbeams to various known peak doses. The measured
fluorescence was used to create a calibration curve against the
delivered dose. Further rods were irradiation to peak doses
that are far above the expected saturation dose that
PRESAGE is capable of measuring to bring the valley dose up
to the sensitive range. This value is compared against the
calibration curve to determine the delivered valley dose and
thus the PVDR. The PRESAGE peak fluorescent responses
from 0 to 15 Gy were used to establish the PRESAGE fluor-
escence calibration curve, and the valleys from peak doses of
50 Gy to 150 Gy were then measured to estimate the PVDR.
3.3. Experiment 3: dose diffusion comparison between
PRESAGE and EBT2 film
In order to evaluate the comparative dose diffusion of
PRESAGE and EBT2, 75 Gy-irradiated samples of each were
compared and the full width at half-maximum (FWHM) was
calculated for each dosimeter.
3.4. Experiment 4: using PRESAGE to measure the
microbeam-collimated radiation’s diffusion through depth
In order to demonstrate the ability of PRESAGE to record
the lack of beam diffusion through depth from synchrotron-
generated microbeams, a rod of PRESAGE was placed hori-
zontally, and the microbeams shot lengthwise to a peak dose of
250 Gy. The irradiated PRESAGE was then scanned with the
CLSM at depths of 20 mm and 100 mm, with the beamwidth
compared between the two to verify beam spatial integrity.
Three images were collected from each depth, with four peaks
shown in each image. The FWHM values for the 12 peaks at
each depth (20 mm and 100 mm) were then compared to see if
there was any difference in beam width.
3.5. Experiment 5: determining the maximum resolution
possible for measuring PRESAGE response by the CLSM
system
In order to demonstrate the upper limits of resolution of the
CLSM, the ‘Maximum Resolution’ data were collected using
the 40 objective lens and recorded as a 4096  4096 image,
giving a nominal pixel size of 78 nm.
4. Results
This section will present the results of the five experiments
outlined in x3, one at a time.
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Figure 3
ImageJ screen capture of the analysis of a valley region of the EBT2 red
channel response.
4.1. Results from experiment 1: EBT2 films PVDR
The EBT2 film response to 2.5–75 Gy microbeams was
analysed, and the regression analysis gave an approximation
to
OD response ¼ 35:377 lnðDoseÞ þ 211:84 or
Dose ¼ exp 211:84OD responseð Þ=35:377½ : ð2Þ
The valley response was sampled from over 4000 pixels from
each EBT2 film that had been irradiated using the microbeam
collimator to 300, 400, 600 and 800 Gy in the peak region. The
range of valley doses from these films was measured to be
between 10 and 35 Gy, which is within the range characterized
by the EBT2 technical specifications (Nariyama et al., 2009).
After smoothing, each response value was then compared with
the established response curve (Fig. 4) and the PVDR calcu-
lated, yielding a [mean  standard deviation (s.d.)] PVDR
value of 30.5  2.6, as shown in Fig. 5.
4.2. Results from experiment 2: PRESAGE PVDR
Using Microsoft Excel 2003’s polynomial fitting feature, a
line of best fit was found for the PRESAGE response over the
dose range 0–15 Gy. The data were modelled on a second-
order polynomial as shown in Fig. 6. This equation was used to
interpolate the valley doses from more heavily irradiated
PRESAGE rods, using the quadratic formula to find the
values of dose which satisfy the regression analysis equation
when ax2 + bx + c = 0, where x in this case is the dose, and
a, b and c are 3.3971, 144.33 and (240.96  fluorescence),
respectively.
The valley fluorescence was sampled from over 4000 pixels
from each PRESAGE dosimeter that had been irradiated to
50, 75, 100 and 150 Gy in the peak region. After smoothing,
each fluorescence value was then compared with the estab-
lished response curve and the PVDR calculated, yielding
a (mean  s.d.) PVDR value of 52.0  6.1, as shown in
Fig. 7.
4.3. Results from experiment 3: dose diffusion in EBT2 and
PRESAGE
At a 10 objective magnification, the transmission of light
through a 75 Gy microbeam-irradiated GAFchromic EBT2
was compared with the fluorescence of a similarly irradiated
PRESAGE rod. The resultant plot in Fig. 8 shows that the
PRESAGE fluorescence measurements exhibit much less
diffusion than the EBT2 film, returning a narrower peak. The
FWHM values for six PRESAGE fluorescence peaks average
(mean  s.d.) 25.6  1.5 mm, and six EBT2 film peaks average
(mean  s.d.) 39.8  2.7 mm, giving a significant difference on
an unpaired t-test (p < 0.01).
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Figure 4
Calibration curve, by regression analysis of EBT2 film. Error bars denote
the standard deviation.
Figure 5
PVDR values from analysis of the EBT2 film scanned data.
Figure 6
Calibration curve, by regression analysis of PRESAGE dosimeters. Error
bars denote the standard deviation.
Figure 7
PVDR values obtained from PRESAGE fluorescence (measuring dose at
a depth of 2.5 mm).
4.4. Results from experiment 4: beam diffusion with depth
Fig. 9 compares the fluorescent images captured by the
CLSM of microbeams at a depth of 20 mm and 100 mm
through the rod. The FWHM of the beam profile was calcu-
lated for the 12 peaks sampled at each depth, giving a FWHM
of (mean  s.d.) 39.7  3.6 mm at 20 mm depth, and 37.9 
2.6 mm at 100 mm depth. This did not show a significant
difference on a two-sample t-test (p = 0.161), and confirms
that the microbeam collimation is not diffusing through to a
clinically useful depth. Note that the FWHM measurements
obtained in this experiment are much higher than for the
PRESAGE rod used in experiment 3, since the peak dose was
250 Gy (compared with 75 Gy in experiment 3). It is therefore
expected that the collimated beam’s penumbra extends to
create a wider FWHM reading.
4.5. Results from experiment 5: microscope settings for
maximum resolution
The maximum resolution recordable by the CLSM is a 4096
 4096 pixel image, and the maximum objective magnification
used was 40. This yields a pixel resolution, in the XY plane,
of 78 nm. Fig. 10 shows the result of such a scan of a
PRESAGE rod, showing a FWHM measurement of 49 mm,
compared with the 20.5 mm measured at 10 magnification.
This illustrates the importance of fixed microscope settings
when determining beam characteristics and comparing results
from different samples using the same settings, and shows the
upper limits of spatial resolution of the detection system.
5. Discussion
This work shows the first known application of fluorescent
microscopy to a PRESAGE dosimeter, and demonstrates the
effectiveness of this technique to measure the synchrotron-
generated microbeam’s important peak-to-valley dose ratio.
This paper also shows that PRESAGE fluorescence can
illustrate the well known property of microbeam-collimated
synchrotron beams to maintain collimation through to a
clinically useful depth. Normal broad-beam radiotherapy
(where field sizes are measured in centimetres) has no need
for pixel resolutions as high as those achieved here, but the
high dose gradient inherent to microbeam collimation
demands that the measurement technique be accurate down to
the micrometre scale.
It should be noted that the large standard deviations of the
PVDR measurements should not come as a surprise, since the
valley doses at the centre of a microbeam array is inherently
higher, owing to scatter from more adjacent peaks, than valley
doses at the edge of a microbeam array (De Felici et al., 2005).
Since all seven valley doses were used to establish the PVDRs
in this study, this variation is expected.
The two different PVDRs calculated using EBT2 film and
PRESAGE (30.5:1 and 52:1, respectively) clearly need
explanation. It is thought that the main reason for this
disagreement is illustrated in Fig. 8, where the dose response
of PRESAGE is shown to have a much narrower response
curve, illustrating that dose diffusion through EBT2 films may
be limiting its usefulness to microbeam valley measurements.
This is thought to be due to the higher sensitivity to low doses
of the EBT2 compared with the PRESAGE rods. A lower
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Figure 10
Maximum resolution of the PRESAGE dosimeter, at 40 objective
magnification. This represents the best possible pixel density, showing a
FWHM measurement for each peak of 49.2 mm and 48.9 mm.
Figure 8
PRESAGE fluorescence (full line) and the transmitted light from
GAFchromic film (dashed line), normalized to their own internal
maximum and minimum values. PRESAGE fluorescence returns a
narrower tighter beam width than the GAFchromic film, indicating less
diffusion. These were taken from images captured at 512  512 pixel
resolution with a 10 objective magnification.
Figure 9
Microbeam profile showing minimal diffusion of the microbeam at a
depth of 20 mm (full line) and 100 mm (dashed line) of the PRESAGE
dosimeter.
PVDR measured by film was also noticed by Torikoshi et al.
(2008), who concluded that scattering owing to silver within
the film was responsible for their higher than expected valley
dose; however, this cannot be the case with the EBT2 films
used in this study which uses no high-Z materials.
It is well established that measuring the PVDR with
different methods, different dosimeters and at different
distances from the collimator will yield different results. This
can be seen in the results summarized by Crosbie et al. (2008),
where the PVDR is estimated at a depth of less than 1 cm as
varying between 29:1 and 53:1. To compound this uncertainty,
there is no single definition of how wide the valley region
should be considered to be, or at what depth or distance from
the collimator it should be measured at (Haryanto et al., 2004;
Siegbahn et al., 2009). The EBT2 PVDR figure of 30.5:1 was
taken from surface measurements, whereas the PRESAGE
PVDR of 52.0:1 was taken from a depth of 2.5 mm. It was
necessary to read the PRESAGE dosimeters at this depth
owing to the curved surface of the dosimeter. This difference
in PVDR value is in line with other papers that have found
that PVDR measurements increase after a few millimetres
depth (De Felici et al., 2005; Crosbie et al., 2008; Wong, 2009).
These values are also within the range of other calculated
PVDRs published for similar geometries and spectra, as
summarized in Table 1.
It is also worth noting that the PVDR values calculated in
this paper are independent of the true dose rate of the
beamline, which as previously stated has been assumed for the
sake of calculation to be 120 Gy s1 (Nariyama et al., 2009).
Since the beamline dose is actually determined by the total
shutter open time of the beamline, the expressions of dose (in
Gy) found in this paper are really scalar multiples of beam
exposure time. Since this beam exposure time was used for the
curve fitting/calibration calculations, and also for the selection
of peak dose for the measurement of valley dosimeter
response, it would not affect the final analysis of the PVDRs if
the true dose rate of the beamline were very different from the
assumed value of 120 Gy s1. Also, a slightly different set of
CLSM settings would produce a different calibration curve
and valley fluorescent response from the PRESAGE rods (as
demonstrated by the change in FWHM in Figs. 8 and 9), but
that would not be expected to alter the calculated PVDR
value.
It was also found that the GAFchromic films (which are
designed to be read by light transmission) also fluoresce with
the use of a 638 nm laser, although not as intensely as the
PRESAGE dosimeter (Fig. 11). These data were not used in
the subsequent analysis; however, it is noted here to demon-
strate that laser-induced fluorescence is not unique to
PRESAGE. Also note that the inhomogeneities present in the
EBT2 film response are indicative of the inherent limitations
to resolution as discussed by Soares (2006), which is thought to
be due to an uneven distribution of chromophores within the
emulsion. Another variable worth noting is the one-month
storage time before analysis of the PRESAGE rods. Although
radiochromic response is known to slightly diminish over time
in PRESAGE dosimeters (Adamovics & Maryanski, 2006),
this will affect both the peak and valley regions and so is not
thought to be a limiting factor to this study.
From a clinical perspective the ratio of irradiated area to
unirradiated area is of great significance, since it will deter-
mine the post-treatment recovery of the tissue. As noted in
experiment 5, changing the CLSM gain and magnification
settings does alter the apparent width of the beam. This effect
must be further investigated before this methodology is
clinically used.
6. Conclusion
The dose record contained in PRESAGE dosimeters can be
read at high resolution by the fluorescent channels of a
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Figure 11
Fluorescent channels of EBT2 film (top) and PRESAGE (bottom). Note
that fluorescence was still detected on the film, but not as clearly as on the
PRESAGE dosimeter.
Table 1
PVDR values from similar studies.
Author PVDR Depth Measurement method Spectrum
Slatkin et al. (1992) 35 0–1 cm CPE Monte Carlo 50, 100 and 150 keV monochromatic X-rays
Crosbie et al. (2008) 55 0 EBT and HD810 film Mean photon energy 125 keV
Siegbahn et al. (2006) 29 0–1 cm Penelope Monte Carlo Mean photon energy 107 keV
De Felici et al. (2005) 40 0.5 cm EGS4 Monte Carlo Peak photon fluence at 107 keV
Nariyama et al. (2009) 77 0.1 cm HD810 film Peak photon fluence at 90 keV
Torikoshi et al. (2008) 12–17 0 EDR2 film Peak photon fluence at 90 keV
Annabell (this work) 31 0 EBT2 film Peak photon fluence at 90 keV
Annabell (this work) 52 0.25 cm PRESEAGE fluorescence Peak photon fluence at 90 keV
confocal microscope. It has also shown that the dose recorded
in a PRESAGE gel is capable of much better resolution than
is used by current OCT systems. PRESAGE is capable of
recording dose deposition with very high resolution, owing
to its low ion diffusion. By contrast, the optical density and
fluorescence data collected from GAFchromic films shows
significant ion diffusion, rendering it unsuitable for recording
dose profiles at submicrometre resolution.
Fluorescent microscopy provides a novel methodology of
obtaining dose distribution data from PRESAGE rods at
submicrometre resolution. Using this, we have shown that
microbeams do not diffuse through 100 mm of tissue-equiva-
lent material, and that this approach has sufficient spatial
resolution to analyze the peak-to-valley ratio of microbeams.
For future work, a depth–dose profile and a study of PVDR
through depth will be generated using this methodology with
stacks of flat-sided PRESAGE dosimeters. It is also feasible to
convert such fluorescent data into a tomogram, in order to
create a full three-dimensional rendering of the dose profile
contained in a PRESAGE rod.
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